Abstract:Abstract Background An outbreak of infection caused by SARS-CoV-2 recently has brought a great challenge to public health. Rapid identification of immune epitopes would be an efficient way to screen the candidates for vaccine development at the time of pandemic. This study aimed to predict the protective epitopes with bioinformatics methods and resources for vaccine development. Methods The genome sequence and protein sequences of SARS-CoV-2 were retrieved from the National Center for Biotechnology Information (NCBI) database. ABCpred and BepiPred servers were utilized for sequential B-cell epitope analysis. Discontinuous B-cell epitopes were predicted via DiscoTope 2.0 program. IEDB server was utilized for HLA-1 and HLA-2 binding peptides computation. Surface accessibility, antigenicity, and other important features of forecasted epitopes were characterized for immunogen potential evaluation. Results A total of 63 sequential B-cell epitopes on spike protein were predicted and 4 peptides (Spike 315–324 , Spike 333–338 , Spike 648–663 , Spike 1064–1079 ) exhibited high antigenicity score and good surface accessibility. Ten residues within spike protein (Gly 496 , Glu 498 , Pro 499 , Thr 500 , Leu 1141 , Gln 1142 , Pro 1143 , Glu 1144 , Leu 1145 , Asp 1146 ) are forecasted as components of discontinuous B-cell epitopes. The bioinformatics analysis of HLA binding peptides within nucleocapsid protein produced 81 and 64 peptides being able to bind MHC class I and MHC class II molecules respectively. The peptides (Nucleocapsid 66–75 , Nucleocapsid 104–112 ) were predicted to bind a wide spectrum of both HLA-1 and HLA-2 molecules. Conclusions B-cell epitopes on spike protein and T-cell epitopes within nucleocapsid protein were identified and recommended for developing a protective vaccine against SARS-CoV-2.

Search for New Potential T-Cell and B-Cell Epitopes in the Spike Protein of SARS-CoV-2

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2

Computational epitope map of SARS-CoV-2 spike protein

T and B cell Epitope analysis of SARS‐CoV‐2 S protein based on immunoinformatics and experimental research

In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19

Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV

The immunodominant and neutralization linear epitopes for SARS-CoV-2

Methods to Identify Immunogenic Peptides in SARS‐CoV‐2 Spike and Protective Monoclonal Antibodies in COVID‐19 Patients

Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies

Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein

Multi Epitopes Potential on Surface SARS-CoV-2 Protein as a Covid-19 Vaccine Candidate

Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus

A Strategy for Searching Antigenic Regions in the SARS-CoV Spike Protein

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines

A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts

Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2

Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach

Immunoinformatic Analysis for the Epitopes on SARS Virus Surface Protein

Identification of Three Conserved Linear B Cell Epitopes on the SARS-CoV-2 Spike Protein

Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2

Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients